[1] Organ Transplantation Branch,Chinese Medical Doctor Association; Chinese Society of Organ Transplantation,Chinese Medical Association. The Chinese clinical practice guideline on liver transplantation for hepatocellular carcinoma(2018)[J]. J Clin Hepatol,2019,35(2):275-280.(in Chinese)中国医师协会器官移植医师分会,中华医学会器官移植学分会.中国肝癌肝移植临床实践指南(2018版)[J].临床肝胆病杂志,2019,35(2):275-280.
|
[2] Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC), Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology. Guidelines for radiofrequency ablation therapy of liver cancer[J]. J Clin Hepatol,2011,27(3):236-238,244.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作委员会,中华医学会肝病学分会肝癌学组.肝癌射频消融治疗规范的专家共识[J].临床肝胆病杂志,2011,27(3):236-238,244.
|
[3] ZENG XX. Research advances in frailty index,a comprehensive index for elderly health[J]. Chin J Gerontol,2010,30(21):3220-3223.(in Chinese)曾宪新.老年健康综合指标———虚弱指数研究进展[J].中国老年学杂志,2010,30(21):3220-3223.
|
[4] GANI F,CERULLO M,AMINI N,et al. Frailty as a risk predictor of morbidity and mortality following liver surgery[J]. J Gastrointest Surg,2017,21(5):822-830.
|
[5] FORTNER JG,LINCER RM. Hepatic resection in the elderly[J]. Ann Surg,1990,211(2):141-145.
|
[6] CUCCHETTI A,PISCAGLIA F,CESCON M,et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma[J]. J Hepatol,2013,59(2):300-307.
|
[7] CABIBBO G,ANTONUCCI M,SACCO R,et al. Ultrasound-guided ablation for hepatocellular carcinoma:Time for a reappraisal?[J]. Expert Rev Anticancer Ther,2015,15(2):147-150.
|
[8] SMITH TJ,MANSKE JG,MATHIASON MA,et al. Changing trends and outcomes in the use of percutaneous cholecystostomy tubes for acute cholecystitis[J]. Ann Surg,2013,257(6):1112-1115.
|
[9] CHA DI,LEE MW,RHIM H,et al. Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations[J]. Korean J Radiol,2013,14(2):240-247.
|